サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1696947

充填・仕上げ医薬品受託製造の世界市場調査レポート：産業分析、規模、シェア、成長、動向、予測（2025年～2033年）

Global Fill-finish Pharmaceutical Contract Manufacturing Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日
ページ情報
英文 130 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.64円
充填・仕上げ医薬品受託製造の世界市場調査レポート：産業分析、規模、シェア、成長、動向、予測（2025年～2033年）
出版日: 2025年03月01日
発行: Value Market Research
ページ情報: 英文 130 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の充填・仕上げ医薬品受託製造の市場規模は、2024年の225億2,000万米ドルから2033年には466億6,000万米ドルに成長し、2026年～2033年の予測期間中に8.43％の堅調な年間平均成長率（CAGR）を示すと予測されます。

バイオ医薬品と個別化医療に対する世界の需要の高まりに伴い、充填・仕上げ医薬品受託製造市場は大きく成長する見通しです。医薬品製剤の複雑化と厳格な規制遵守の必要性に伴い、製薬会社は充填・仕上げ工程を専門の受託製造業者に委託する傾向が強まっています。この動向の背景には、製品の安全性と有効性を確保するために不可欠な、無菌処理に関する高度な技術と専門知識の必要性があります。バイオ医薬品セクターの拡大が続く中、充填・仕上げ部門も進化を遂げ、最先端の自動化やロボット工学を取り入れて効率を高め、人的ミスを減らすことが期待されています。

さらに、生物製剤とバイオシミラーの台頭は、充填・仕上げ製造の状況を再構築しつつあります。これらの複雑な分子は、特殊な取り扱いや包装技術を必要とするため、従来の製造設備では対応できないことが多いです。受託製造企業は、こうした需要に対応するため、アイソレーターや高度な無菌処理技術を備えた最先端の施設に投資しています。さらに、持続可能性と環境に優しい慣行への注目の高まりは、メーカーに環境に優しい技術と材料の採用を促し、充填・仕上げ部門の技術革新をさらに促進しています。規制機関が製造慣行に対する監視を強化する中、品質保証とコンプライアンスが重視されることも、この市場の成長を促進すると思われます。

今後、充填・仕上げ医薬品受託製造市場では、製薬企業と受託製造業者間の提携や協力関係が急増すると予想されます。このような戦略的連携により、各社は互いの強みを活用し、新治療薬の市場投入までの時間を短縮することが可能になります。 さらに、IoTやAIなどのデジタル技術の統合は、業務効率を高め、リアルタイムのデータ分析を提供し、より良い意思決定と資源配分を可能にします。業界が進化する市場力学に適応し続ける中、充填・仕上げ部門は医薬品製造の全体的な成功において極めて重要な役割を果たし、革新的な治療法がタイムリーかつ安全な方法で患者に届くことを確実にします。

当社のレポートは、様々な業界や市場に関する包括的かつ実用的な洞察をお客様に提供するために綿密に作成されています。各レポートは、市場情勢を完全に理解するために、いくつかの重要な要素を含んでいます：

市場概要：定義、分類、業界の現状など、市場に関する詳細なイントロダクションです。

市場力学：市場成長に影響を与える主な促進要因・抑制要因・機会・課題を詳細に分析します。このセクションでは、技術の進歩、規制の変更、新たな動向などの要因を検証します。

セグメンテーション分析：製品タイプ、用途、エンドユーザー、地域などの基準に基づき、市場を明確なセグメントに分けています。この分析により、各セグメントの業績と将来性を明らかにします。

競合情勢：市場シェア、製品ポートフォリオ、戦略的イニシアティブ、財務実績など、主要市場企業を包括的に評価しています。主要企業が採用する競合力学と主要戦略に関する考察を提供します。

市場予測：実績データと現在の市場状況に基づき、一定期間における市場規模と成長動向を予測しています。これには、定量的分析と将来の市場軌跡を示すグラフ表示が含まれます。

地域分析：地域ごとの市場パフォーマンスを評価し、主要市場や地域動向を明らかにします。地域の市場力学とビジネスチャンスを理解するのに役立ちます。

新たな動向と機会：現在の市場動向と新たな市場動向、技術革新、潜在的な投資対象分野を特定します。将来の市場開拓と成長見通しに関する洞察を提供します。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 充填・仕上げ医薬品受託製造業界の分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 世界の充填・仕上げ医薬品受託製造市場分析：製品別

  • 製品別の概要
  • 製品別の実績・予測データ分析
  • プレフィルドシリンジ
  • バイアル
  • カートリッジ
  • その他

第6章 世界の充填・仕上げ医薬品受託製造市場分析：分子別

  • 分子別の概要
  • 分子別の実績・予測データ分析
  • 高分子
  • 低分子

第7章 世界の充填・仕上げ医薬品受託製造市場分析：最終用途別

  • 最終用途別の概要
  • 最終用途別の実績・予測データ分析
  • バイオ医薬品企業
  • 製薬企業

第8章 世界の充填・仕上げ医薬品受託製造市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米の売上分析
    • 概要・実績・予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州の売上分析
    • 概要・実績・予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他欧州
  • アジア太平洋の売上分析
    • 概要・実績・予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他アジア太平洋
  • ラテンアメリカの売上分析
    • 概要・実績・予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他ラテンアメリカ
  • 中東・アフリカの売上分析
    • 概要・実績・予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東・アフリカ

第9章 充填・仕上げ医薬品受託製造企業の競合情勢

  • 充填・仕上げ医薬品受託製造市場の競合
  • 提携・協力・協定
  • 合併・買収
  • 新製品発売
  • その他の開発

第10章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • Thermo Fisher Scientific Inc.
  • Sartorius AG
  • Boehringer Ingelheim International GmbH
  • Catalent Inc.（Which Was Acquired By Novo Holdings A/S）
  • Societal CDMO（Formerly Recro Pharma Inc.）
  • Baxter
  • Eurofins Scientific
  • Symbiosis Pharmaceutical Services Ltd.
  • MabPlex International Co. Ltd.
  • Recipharm AB
  • Fresenius Kabi USA LLC
  • Lonza
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product (USD MN)
  • Prefilled Syringes Market Sales By Geography (USD MN)
  • Vials Market Sales By Geography (USD MN)
  • Cartridges Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Molecule (USD MN)
  • Large Molecules Market Sales By Geography (USD MN)
  • Small Molecules Market Sales By Geography (USD MN)
  • Analysis By End Use (USD MN)
  • Biopharmaceutical Companies Market Sales By Geography (USD MN)
  • Pharmaceutical Companies Market Sales By Geography (USD MN)
  • Global Fill-finish Pharmaceutical Contract Manufacturing Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Fill-finish Pharmaceutical Contract Manufacturing Report
  • Market Research Process
  • Market Research Methodology
  • Global Fill-finish Pharmaceutical Contract Manufacturing Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By Molecule
  • Market Attractiveness Analysis By End Use
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product (USD MN)
  • Prefilled Syringes Market Sales By Geography (USD MN)
  • Vials Market Sales By Geography (USD MN)
  • Cartridges Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Molecule (USD MN)
  • Large Molecules Market Sales By Geography (USD MN)
  • Small Molecules Market Sales By Geography (USD MN)
  • Global Market Analysis By End Use (USD MN)
  • Biopharmaceutical Companies Market Sales By Geography (USD MN)
  • Pharmaceutical Companies Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR112114625

Global Fill-finish Pharmaceutical Contract Manufacturing Market size is anticipated to grow from USD 22.52 Billion in 2024 to USD 46.66 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 8.43% during the forecast period of 2026 to 2033.

The fill-finish pharmaceutical contract manufacturing market is poised for significant growth as the global demand for biopharmaceuticals and personalized medicine escalates. With the increasing complexity of drug formulations and the need for stringent regulatory compliance, pharmaceutical companies are increasingly outsourcing their fill-finish processes to specialized contract manufacturers. This trend is driven by the necessity for advanced technologies and expertise in sterile processing, which are critical for ensuring product safety and efficacy. As the biopharmaceutical sector continues to expand, the fill-finish segment is expected to evolve, incorporating cutting-edge automation and robotics to enhance efficiency and reduce human error.

Moreover, the rise of biologics and biosimilars is reshaping the landscape of fill-finish manufacturing. These complex molecules require specialized handling and packaging techniques, which are often beyond the capabilities of traditional manufacturing setups. Contract manufacturers are investing in state-of-the-art facilities equipped with isolators and advanced aseptic processing technologies to meet these demands. Additionally, the increasing focus on sustainability and eco-friendly practices is prompting manufacturers to adopt greener technologies and materials, further driving innovation in the fill-finish sector. As regulatory bodies tighten their scrutiny on manufacturing practices, the emphasis on quality assurance and compliance will also catalyze growth in this market.

Looking ahead, the fill-finish pharmaceutical contract manufacturing market is expected to witness a surge in partnerships and collaborations between pharmaceutical companies and contract manufacturers. This strategic alignment will enable companies to leverage each other's strengths, facilitating faster time-to-market for new therapies. Furthermore, the integration of digital technologies, such as IoT and AI, will enhance operational efficiencies and provide real-time data analytics, allowing for better decision-making and resource allocation. As the industry continues to adapt to evolving market dynamics, the fill-finish segment will play a pivotal role in the overall success of pharmaceutical manufacturing, ensuring that innovative therapies reach patients in a timely and safe manner.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Product

  • Prefilled Syringes
  • Vials
  • Cartridges
  • Others

By Molecule

  • Large Molecules
  • Small Molecules

By End Use

  • Biopharmaceutical Companies
  • Pharmaceutical Companies
  • COMPANIES PROFILED
  • Thermo Fisher Scientific Inc.
  • Sartorius AG
  • Boehringer Ingelheim International GmbH
  • Catalent Inc. (which was acquired by Novo Holdings A/S)
  • Societal CDMO (formerly Recro Pharma Inc.)
  • Baxter
  • Eurofins Scientific
  • Symbiosis Pharmaceutical Services Ltd.
  • MabPlex International Co. Ltd.
  • Recipharm AB
  • Fresenius Kabi USA LLC
  • Lonza
  • The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Molecule
    • 3.7.3 Market Attractiveness Analysis By End Use
    • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET ANALYSIS BY PRODUCT

  • 5.1. Overview By Product
  • 5.2. Historical and Forecast Data Analysis By Product
  • 5.3. Prefilled Syringes Historic and Forecast Sales By Regions
  • 5.4. Vials Historic and Forecast Sales By Regions
  • 5.5. Cartridges Historic and Forecast Sales By Regions
  • 5.6. Others Historic and Forecast Sales By Regions

6. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET ANALYSIS BY MOLECULE

  • 6.1. Overview By Molecule
  • 6.2. Historical and Forecast Data Analysis By Molecule
  • 6.3. Large Molecules Historic and Forecast Sales By Regions
  • 6.4. Small Molecules Historic and Forecast Sales By Regions

7. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET ANALYSIS BY END USE

  • 7.1. Overview By End Use
  • 7.2. Historical and Forecast Data Analysis By End Use
  • 7.3. Biopharmaceutical Companies Historic and Forecast Sales By Regions
  • 7.4. Pharmaceutical Companies Historic and Forecast Sales By Regions

8. GLOBAL FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2 North America By Segment Sales Analysis
    • 8.3.3 North America By Country Sales Analysis
    • 8.3.4 United States Sales Analysis
    • 8.3.5 Canada Sales Analysis
    • 8.3.6 Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2 Europe By Segment Sales Analysis
    • 8.4.3 Europe By Country Sales Analysis
    • 8.4.4 United Kingdom Sales Analysis
    • 8.4.5 France Sales Analysis
    • 8.4.6 Germany Sales Analysis
    • 8.4.7 Italy Sales Analysis
    • 8.4.8 Russia Sales Analysis
    • 8.4.9 Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2 Asia Pacific By Segment Sales Analysis
    • 8.5.3 Asia Pacific By Country Sales Analysis
    • 8.5.4 China Sales Analysis
    • 8.5.5 India Sales Analysis
    • 8.5.6 Japan Sales Analysis
    • 8.5.7 South Korea Sales Analysis
    • 8.5.8 Australia Sales Analysis
    • 8.5.9 South East Asia Sales Analysis
    • 8.5.10 Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2 Latin America By Segment Sales Analysis
    • 8.6.3 Latin America By Country Sales Analysis
    • 8.6.4 Brazil Sales Analysis
    • 8.6.5 Argentina Sales Analysis
    • 8.6.6 Peru Sales Analysis
    • 8.6.7 Chile Sales Analysis
    • 8.6.8 Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2 Middle East & Africa By Segment Sales Analysis
    • 8.7.3 Middle East & Africa By Country Sales Analysis
    • 8.7.4 Saudi Arabia Sales Analysis
    • 8.7.5 UAE Sales Analysis
    • 8.7.6 Israel Sales Analysis
    • 8.7.7 South Africa Sales Analysis
    • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING COMPANIES

  • 9.1. Fill-finish Pharmaceutical Contract Manufacturing Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10. COMPANY PROFILES OF FILL-FINISH PHARMACEUTICAL CONTRACT MANUFACTURING INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Thermo Fisher Scientific Inc.
    • 10.3.1 Company Overview
    • 10.3.2 Company Revenue
    • 10.3.3 Products
    • 10.3.4 Recent Developments
  • 10.4. Sartorius AG
    • 10.4.1 Company Overview
    • 10.4.2 Company Revenue
    • 10.4.3 Products
    • 10.4.4 Recent Developments
  • 10.5. Boehringer Ingelheim International GmbH
    • 10.5.1 Company Overview
    • 10.5.2 Company Revenue
    • 10.5.3 Products
    • 10.5.4 Recent Developments
  • 10.6. Catalent Inc. (Which Was Acquired By Novo Holdings A/S)
    • 10.6.1 Company Overview
    • 10.6.2 Company Revenue
    • 10.6.3 Products
    • 10.6.4 Recent Developments
  • 10.7. Societal CDMO (Formerly Recro Pharma Inc.)
    • 10.7.1 Company Overview
    • 10.7.2 Company Revenue
    • 10.7.3 Products
    • 10.7.4 Recent Developments
  • 10.8. Baxter
    • 10.8.1 Company Overview
    • 10.8.2 Company Revenue
    • 10.8.3 Products
    • 10.8.4 Recent Developments
  • 10.9. Eurofins Scientific
    • 10.9.1 Company Overview
    • 10.9.2 Company Revenue
    • 10.9.3 Products
    • 10.9.4 Recent Developments
  • 10.10. Symbiosis Pharmaceutical Services Ltd.
    • 10.10.1 Company Overview
    • 10.10.2 Company Revenue
    • 10.10.3 Products
    • 10.10.4 Recent Developments
  • 10.11. MabPlex International Co. Ltd.
    • 10.11.1 Company Overview
    • 10.11.2 Company Revenue
    • 10.11.3 Products
    • 10.11.4 Recent Developments
  • 10.12. Recipharm AB
    • 10.12.1 Company Overview
    • 10.12.2 Company Revenue
    • 10.12.3 Products
    • 10.12.4 Recent Developments
  • 10.13. Fresenius Kabi USA LLC
    • 10.13.1 Company Overview
    • 10.13.2 Company Revenue
    • 10.13.3 Products
    • 10.13.4 Recent Developments
  • 10.14. Lonza
    • 10.14.1 Company Overview
    • 10.14.2 Company Revenue
    • 10.14.3 Products
    • 10.14.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies